METHODS	Post-hoc exploratory analyses of data from 270 postmenopausal women randomized to 2 years ' therapy with daily nasal administration of 17beta-estradiol or placebo sequentially combined with oral micronized progesterone in the active groups or placebo in the placebo group .\